Resalis Therapeutics Announces Seed Financing of €10

Resalis Therapeutics today announced its completion of the seed financing round of €10 million to establish a non-coding RNA (ncRNA)-based therapeutic approach for the treatment of metabolic diseases.

Related Keywords

Italy , Italian , Dennis Riedl , Alessandro Toniolo , Riccardo Panella , Pietro Puglisi , Sakari Kauppinen , Charlotte Spitz , Pfizer , Aalborg University , Trophic Communications , Novartis , Resalis Therapeutics , Claris Ventures , Italian Angels , Managing Partner , Resali Board , Resalis , Herapeutics , Nnounces , Need , Financing , Billion , Fund , Coding , Ased , Etabolic , Diseases ,